Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Anemia, Sickle Cell: early-phase trial registry
3 of 18 indexed Anemia, Sickle Cell trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #953 of 28,707 conditions by registered trial count.
18 US clinical trials · 3 currently recruiting · #953 of 28,707 conditions by registered trial count
Anemia, Sickle Cell: 18 US clinical trials tracked, 3 recruiting.
Anemia, Sickle Cell is the subject of 18 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is Duke University, running 2 of these trials.
Enrollment posture brief
Registry condition anemia-sickle-cell
OPEN 3 | RECR 17% | LATE 1 | EARLY 7 | RANK #953 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Renal Failure (17% recruiting · 6 trials)
Anemia, Sickle Cell lists 3 open slots (17% of 18 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Anemia, Sickle Cell on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Anemia, Sickle Cell is recruiting below its size-band peers.
3 of 18 indexed trials (16.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Anemia, Sickle Cell trials is spread across many organizations.
Duke University accounts for 2 of 18 trials (11.1%). 16 distinct sponsors appear on at least one study for this condition label.
-
Typical Anemia, Sickle Cell enrolment sits around 102 participants.
Median target enrolment is 102 among the 18 trials that report a genuine target (sentinel values excluded). 9 of those (50%) plan for fewer than 100 participants.
-
Anemia, Sickle Cell research is mostly interventional.
15 interventional and 3 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
18 total, page 1 of 1
A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
Children's Hospital Medical Center, Cincinnati
NCT06290401
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Bristol-Myers Squibb
NCT06481306
Metabolic and Hemodynamic Reserve in Pediatric SCA
Washington University School of Medicine
NCT04406818
Therapeutic Response Evaluation and Adherence Trial (TREAT)
Children's Hospital Medical Center, Cincinnati
NCT02286154
Epidemiology of Silent and Overt Strokes in Sickle Cell Disease
Vanderbilt University Medical Center
NCT03376893
Telemedicine for Children With Sickle Cell Disease
Indiana University
NCT05087303
A Blood Stem Cell Transplant for Sickle Cell Disease
City of Hope Medical Center
NCT03249831
Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease
University of Illinois at Chicago
NCT00600665
Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease
Duke University
NCT04584528
Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises
Mallinckrodt
NCT00094887
Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisis
Montefiore Medical Center
NCT01482091
Feasibility and Efficacy of a Home-based, Computerized Cognitive Training Program in Pediatric Sickle Cell Disease
Steven J. Hardy
NCT02857023
MBSR for Pain Catastrophizing in SCD
Duke University
NCT02394587
A Self-Management Intervention for Youth With Sickle Cell Disease and Their Families: Phase I
Medical University of South Carolina
NCT03069430
Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study
UCSF Benioff Children's Hospital Oakland
NCT00850018
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
National Heart, Lung, and Blood Institute (NHLBI)
NCT00029380
Hydroxyurea and EPO in Sickle Cell Disease
Julia Xu
NCT05451940
Quality of Life of Children With Sickle Cell Disease Who Are Getting Chronic Transfusions With a Lifeport
Children's Mercy Hospital Kansas City
NCT00246077
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 3 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Anemia, Sickle Cell records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Anemia, Sickle Cell trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Anemia, Sickle Cell page
18 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Anemia, Sickle Cell trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Duke University sponsors the most Anemia, Sickle Cell trials on record, review their full trial history before evaluating a specific study. See Duke University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Anemia, Sickle Cell condition card totals 18 registered trials; most-linked intervention Hydroxyurea; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.